Salman Rawaf
Impact in
- Health, Toxicology and Mutagenesis top 0.05%
- Air Quality and Health Impacts
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Global Health and Epidemiology 9
- Co-authors
- Azeem Majeed (21 shared papers)G. Hussein Rassool (4 shared papers)Harumi Yamamoto (8 shared papers)Emilie Karafillakis (1 shared paper)Haitham Shoman (1 shared paper)Luke Nelson Allen (2 shared papers)David Laith Rawaf (5 shared papers)Chris van Weel (3 shared papers)
- Journals
- The Lancet (51 papers)The Lancet Global Health (11 papers)The Lancet Public Health (9 papers)The Lancet Neurology (9 papers)The Lancet. Gastroenterology & hepatology (8 papers)
- Partner nations
- United StatesUnited KingdomIran
In The Last Decade
Salman Rawaf
233 papers receiving 139.6k citations
Salman Rawaf's Hit Papers
Peers
Comparison fields: 5 of 218
- Health, Toxicology and Mutagenesis 5.3k
- Nephrology 3.4k
- Psychiatry and Mental health 6.1k
- Applied Microbiology and Biotechnology 666
- Pharmacology 4.1k
Countries citing papers authored by Salman Rawaf
This map shows the geographic impact of Salman Rawaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salman Rawaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salman Rawaf more than expected).
Fields of papers citing papers by Salman Rawaf
This network shows the impact of papers produced by Salman Rawaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salman Rawaf. The network helps show where Salman Rawaf may publish in the future.
Co-authors
The 25 scholars most cited alongside Salman Rawaf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 240 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2020 | 13876 |
| 2 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2017 | 10938 |
| 3 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 10887 |
| 4 | Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2020 | 7042 |
| 5 | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 6792 |
| 6 | Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2021 | 5410 |
| 7 | Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2020 | 4976 |
| 8 | Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2019 | 4329 |
| 9 | Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2017 | 4004 |
| 10 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Hit paper breakdown → | 2018 | 3958 |
| 11 | Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 3606 |
| 12 | Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 Hit paper breakdown → | 2017 | 3045 |
| 13 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 3041 |
| 14 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2997 |
| 15 | Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2018 | 2573 |
| 16 | Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study Hit paper breakdown → | 2020 | 2170 |
| 17 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Hit paper breakdown → | 2017 | 2022 |
| 18 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Hit paper breakdown → | 2019 | 1969 |
| 19 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1965 |
| 20 | Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Hit paper breakdown → | 2017 | 1892 |
About Salman Rawaf
Salman Rawaf is a scholar working on Health Information Management, General Health Professions, Demography, Infectious Diseases and Epidemiology, having authored 240 papers that have together received 143.9k indexed citations. Recurring topics across this work include Insurance, Mortality, Demography, Risk Management (13 papers), Global Cancer Incidence and Screening (9 papers), Global Health and Epidemiology (9 papers), Cardiovascular Health and Risk Factors (8 papers), Substance Abuse Treatment and Outcomes (6 papers), Injury Epidemiology and Prevention (5 papers), HIV/AIDS Research and Interventions (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (5.3k citations), Nephrology (3.4k citations), Psychiatry and Mental health (6.1k citations), Applied Microbiology and Biotechnology (666 citations) and Pharmacology (4.1k citations). Salman Rawaf has collaborated with scholars based in United States, United Kingdom and Iran. Frequent co-authors include Azeem Majeed, G. Hussein Rassool, Harumi Yamamoto, Emilie Karafillakis, Haitham Shoman, Luke Nelson Allen, David Laith Rawaf, Chris van Weel, Dionne Sofia Kringos and Sondus Hassounah. Their work appears in journals such as The Lancet, The Lancet Global Health, The Lancet Public Health, The Lancet Neurology and The Lancet. Gastroenterology & hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.